Can Quality of Life Tests Be Useful in Patients Affected by Alpha-1 Antitrypsin Deficiency? [PDF]
Hernández-Pérez JM +3 more
europepmc +1 more source
Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye. [PDF]
Karadoğan D +8 more
europepmc +1 more source
Selection for somatic escape variants in SERPINA1 in the liver of patients with alpha-1 antitrypsin deficiency. [PDF]
Brzozowska N +11 more
europepmc +1 more source
Fazirsiran for the treatment of alpha-1 antitrypsin deficiency-associated liver disease findings from the SEQUOIA phase 2 trial. [PDF]
Liaquat T +5 more
europepmc +1 more source
Clinical and Economic Outcomes in Patients With Alpha-1 Antitrypsin Deficiency in a US Medicare Advantage Population. [PDF]
Khandelwal N +8 more
europepmc +1 more source
Signs of Hyperinflation and Ventilation Heterogeneity in Individuals With Severe Alpha-1-Antitrypsin Deficiency at the Age of 42. [PDF]
Schramm GR +4 more
europepmc +1 more source
Related searches:
Alpha-1 Antitrypsin Deficiency
Methods in molecular biology, 2023Alpha-1 antitrypsin (AAT) deficiency is a common monogenic disorder in which there is a strong founder effect of a single missense mutation in SERPINA1, the gene encoding this major circulating serum anti-protease that is normally expressed primarily in hepatocytes.
Alisha M, Gruntman +2 more
semanticscholar +4 more sources
Alpha‐1‐Antitrypsin Deficiency
Clinical Liver Disease, 2022Content available: Author Audio Recording.
Anandini Suri +2 more
openaire +4 more sources

